Eszter M. Tichy

Ivry-sur-seine, 94853, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Public Health Impact of Potential Infant MenACWY Vaccination Strategies in Spain.

Public Health Impact of Potential Infant MenACWY Vaccination Strategies in Spain.

Journal: Vaccines

Published: March 27, 2025

Public health impact and cost-effectiveness of introducing MenACWY vaccination strategies in Germany.

Public health impact and cost-effectiveness of introducing MenACWY vaccination strategies in Germany.

Journal: BMC public health

Published: September 25, 2023

Economic burden of antimicrobial resistance and inappropriate empiric treatment in Thailand.

Economic burden of antimicrobial resistance and inappropriate empiric treatment in Thailand.

Journal: Antimicrobial stewardship & healthcare epidemiology : ASHE

Published: February 14, 2023

Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK: Does the Adolescent MenACWY Programme Provide Sufficient Protection?

Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK: Does the Adolescent MenACWY Programme Provide Sufficient Protection?

Journal: Vaccines

Published: February 13, 2023

Identification of an Optimal COVID-19 Booster Allocation Strategy to Minimize Hospital Bed-Days with a Fixed Healthcare Budget.

Identification of an Optimal COVID-19 Booster Allocation Strategy to Minimize Hospital Bed-Days with a Fixed Healthcare Budget.

Journal: Vaccines

Published: December 21, 2022

Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy.

Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy.

Journal: Clinical therapeutics

Published: November 11, 2019

Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI).

Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI).

Journal: Antimicrobial resistance and infection control

Published: September 06, 2019

Cost-effectiveness analysis of ceftazidime/avibactam compared to imipenem as empirical treatment for complicated urinary tract infections.

Cost-effectiveness analysis of ceftazidime/avibactam compared to imipenem as empirical treatment for complicated urinary tract infections.

Journal: International journal of antimicrobial agents

Published: November 02, 2018

Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.

Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.

Journal: PharmacoEconomics

Published: September 25, 2016

Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective.

Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective.

Journal: Journal of medical economics

Published: May 26, 2016

Crystal structure of the carbapenem intrinsic resistance protein CarG.

Crystal structure of the carbapenem intrinsic resistance protein CarG.

Journal: Journal of molecular biology

Published: December 30, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026